Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sales & Earnings In Brief

This article was originally published in The Tan Sheet

Executive Summary

Bausch & Lomb: Worldwide lens care sales rose 8% to $121 mil. in Q4, led by ReNu products' double-digit gains in the Americas and Asia, according to Jan. 30 1company announcement. For the year, lens care revenues advanced 12% to $465.5 mil. Positive lens care performance, along with similar strong gains in contact lens and pharmaceuticals sales, helped power 9% overall sales increase to $1.81 bil. in 2002 versus the previous year, firm reports; full year net earnings rose to $72.5 mil. in 2002 from $21.2 mil. a year ago. B&L expects "low single-digit growth in" lens care sales in 2003. Additionally, Chairman & CEO Ronald Zarrella will oversee firm's Americas region commercial business until a successor is named for B&L exec Mark Sieczkarek, who left Jan. 31 "to pursue career opportunities elsewhere"...

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS095121

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel